Clinical Benefit from Tyrosine Kinase Inhibitors in Metastatic Merkel Cell Carcinoma: A Case Series of 5 Patients

Case series Patients: Male, 58 • Male, 65 • Male, 75 • Male, 61 • Male, 69 Final Diagnosis: Merkel cell carcinoma Symptoms: Metastatic disease Medication: Pazopanib • Cabozantinib Clinical Procedure: Systemic therapy Specialty: Oncology OBJECTIVE: Rare disease BACKGROUND: Merkel cell carcinoma (MCC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Tarabadkar, Erica S., Thomas, Hannah, Blom, Astrid, Parvathaneni, Upendra, Olencki, Thomas, Nghiem, Paul, Bhatia, Shailender
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952731/
https://www.ncbi.nlm.nih.gov/pubmed/29706615
http://dx.doi.org/10.12659/AJCR.908649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952731/
https://www.ncbi.nlm.nih.gov/pubmed/29706615
http://dx.doi.org/10.12659/AJCR.908649

Ejemplares similares